Last reviewed · How we verify

NCT05080309: soliso-2

Effect of Oral Carbohydrate Intake > 44kCal Per Hour During Labour on the Rate of Instrumental Vaginal Delivery

Recruiting now NA Last updated 25 July 2025
What this trial tests

NA trial testing carbohydrate oral intake in Delivery Complication in 600 participants. Currently enrolling.

Timeline
11 February 2022
Primary endpoint
1 February 2028
3 September 2028

Quick facts

Lead sponsorUniversity Hospital, Caen
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment600
Start date11 February 2022
Primary completion1 February 2028
Estimated completion3 September 2028
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Caen

Who can join

Adults 18 to 60, female only, with Delivery Complication or Labor Long. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Carbohydrate intake during physical exercise improves muscle performance and decreases fatigue. We hypothesized that carbohydrate intake during labor which is a period of significant physical activity can decrease the instrumental vaginal delivery rate. In a previous study we reported a trend toward a decrease in instrumental vaginal delivery and the mount of carbohydrate intake during labour. However due to some limitations no clear conclusion could be drawn. The present study is designed to examine the relationship between a high calory oral intake (\>44 kCal/hour during labour) and the rate of instrumental delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Delivery Complication

Currently open trials in the same condition.

Other University Hospital, Caen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05080309.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing